Pharmacokinetics of isoforskolin after administration via different routes in guinea pigs.

Tingting Feng,Yong Li,Jun Chen,Yong Chen,Jianming Huang,Weiyu Weng
DOI: https://doi.org/10.3109/00498254.2015.1099082
2016-01-01
Xenobiotica
Abstract:1.The objective of this study was to characterize the pharmacokinetics of isoforskolin after oral, intraperitoneal and intravenous administration, as well as to compare bioavailability.2.Isoforskolin was administered to guinea pigs at a dose of 2mg/kg. Plasma concentrations were determined by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry (HPLC-ESI-MS/MS) method. The pharmacokinetic parameters were calculated by a noncompartmental method. A compartment model was also adopted to describe the pharmacokinetic profiles.3.The pharmacokinetic behavior of intravenously administered isoforskolin was characterized by rapid and extensive distribution (V-z=16.828.42L/kg) followed by rapid elimination from the body (Cl=9.63 +/- 4.21L/kg/h). After intraperitoneal administration, isoforskolin was absorbed rapidly (T-max=0.12 +/- 0.05h). The pharmacokinetic profiles of isoforskolin were similar after intraperitoneal and intravenous administration, except for the concentrations at the initial sampling times. Isoforskolin was also absorbed rapidly following oral dosing; however, the concentration-time data were best fit to a one-compartment model, which was different from that observed after intravenous and intraperitoneal administration. Following intraperitoneal and oral administration, the absolute bioavailability of isoforskolin was 64.12% and 49.25%, respectively.4.Isoforskolin is a good candidate for oral administration because of its good oral bioavailability.
What problem does this paper attempt to address?